Human germline-like monoclonal antibody against 5T4 enables potent ADC and CAR-T therapies for solid tumors.
2/5 보강
TL;DR
The germline-like antibody as a versatile platform for 5T4-targeted therapies offers promising immunotherapies for treating solid tumors.
OpenAlex 토픽 ·
CAR-T cell therapy research
Monoclonal and Polyclonal Antibodies Research
Cancer Immunotherapy and Biomarkers
The germline-like antibody as a versatile platform for 5T4-targeted therapies offers promising immunotherapies for treating solid tumors.
APA
Yi-qing Jiang, Xiao-jie Ma, et al. (2026). Human germline-like monoclonal antibody against 5T4 enables potent ADC and CAR-T therapies for solid tumors.. Acta pharmacologica Sinica, 47(5), 1326-1337. https://doi.org/10.1038/s41401-025-01731-3
MLA
Yi-qing Jiang, et al.. "Human germline-like monoclonal antibody against 5T4 enables potent ADC and CAR-T therapies for solid tumors.." Acta pharmacologica Sinica, vol. 47, no. 5, 2026, pp. 1326-1337.
PMID
41593208 ↗
Abstract 한글 요약
5T4 is an oncofetal antigen overexpressed in a wide range of solid tumors with minimal presence in normal adult tissues, highlighting its promise as a therapeutic target. In this study, we identified germline-like human monoclonal antibodies targeting human 5T4 with high affinity, among which antibody m603 exhibits superior cell binding activity to various cancer cells including breast, pancreatic, ovarian, lung and liver cancer cell lines. Subsequently, we constructed antibody-drug conjugates (ADCs) and chimeric antigen receptor (CAR)-T cell based on m603. By conjugating the antibody with cytotoxic payload DM4 or MMAE, the resulting ADCs demonstrated potent and antigen-dependent cell killing activity in vitro. The ADC conjugated with MMAE payload elicited durable tumor suppression in pancreatic cancer xenograft models. Furthermore, third-generation CAR-T cells derived from m603 (603z-CAR-T), incorporating 4-1BB and CD28 costimulatory domains, effectively induced IFN-γ and IL-2 secretion and remarkable tumor eradication. The germline-like antibody as a versatile platform for 5T4-targeted therapies offers promising immunotherapies for treating solid tumors.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
- Humans
- Animals
- Antibodies
- Monoclonal
- Immunoconjugates
- Cell Line
- Tumor
- Receptors
- Chimeric Antigen
- Xenograft Model Antitumor Assays
- Immunotherapy
- Adoptive
- Mice
- Female
- Neoplasms
- Membrane Glycoproteins
- 5T4
- antibody-drug conjugate
- chimeric antigen receptor T cell
- germline-like monoclonal antibody
- pancreatic cancer
- solid tumors
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.